Drug Information

Drug General Information
Drug ID
D0A5SA
Former ID
DNCL003785
Drug Name
TAK-272
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 2 [525048]
Company
Takeda
Target and Pathway
Target(s) Renin, renal Target Info Modulator [549203]
KEGG Pathway Renin-angiotensin system
PathWhiz Pathway Angiotensin Metabolism
Reactome Metabolism of Angiotensinogen to Angiotensins
WikiPathways ACE Inhibitor Pathway
Metabolism of Angiotensinogen to Angiotensins
References
Ref 525048ClinicalTrials.gov (NCT02332824) A Phase 2 Dose-finding Study of TAK-272 in Patients With Type 2 Diabetes Mellitus and Microalbuminuria. U.S. National Institutes of Health.
Ref 549203Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033655)

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.